Design
Review
Authors
Loading...
May support NAD(P)H oxidase inhibition in hypertension and atherosclerosis; leaves open need for clinical trials.
Hanna et al. (2002) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: